X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-85.62M
↓ 30% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-65.83M
Historical baseline
PeriodValueYoY Change
TTM$-85.62M+34.6%
2024$-130.90M-35.6%
2023$-96.51M-25.2%
2022$-77.10M-8.7%
2021$-70.91M-20.5%
2020$-58.82M-22.4%
2019$-48.05M-17.5%
2018$-40.90M-46.8%
2017$-27.87M-28.8%
2016$-21.64M-